在日本患者中,PTCL-TBX21和PTCL-GATA3之间的临床病理比较
Yasumasa Shimasaki1,2, Hiroaki Miyoshi1, Keisuke Kawamoto1,3
1Department of Pathology, School of Medicine, Kurume University, Kurume, Japan.
Cancer medicine
|January 18, 2024
概括
将PTCL-NOS分类为PTCL-TBX21和PTCL-GATA3亚型有助于预测日本患者的预后. PTCL-GATA3的存活率较低,这表明其在临床实践中的价值.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 周围T细胞淋巴瘤没有另有说明 (PTCL-NOS) 是一组多样化的侵略性非霍奇金淋巴瘤.
- 在分子层面上,PTCL-NOS可以分为PTCL-TBX21和PTCL-GATA3亚型,表明它们具有不同的生物行为.
- 了解亚型特定的临床病理特征对于准确的诊断和治疗策略至关重要.
研究的目的:
- 为了比较日本队列中PTCL-NOS亚型 (PTCL-TBX21和PTCL-GATA3) 的临床病理特征.
- 评估这些亚型在患者存活率方面的预后意义.
- 探索这种分类在指导治疗决策方面的潜力,包括使用免疫检查点抑制剂.
主要方法:
- 一组100名PTCL-NOS患者被分为PTCL-TBX21,PTCL-GATA3或未分类组,使用免疫组织化学 (IHC) 算法.
- 临床病理特征,包括CD4阳性和高内皮静脉计数,在亚型之间进行了比较.
- 进行基因表达分析 (nCounter系统),以评估与瘤免疫相关的基因.
- 总生存率 (OS) 和无进展生存率 (PFS) 用单变量和多变量方法进行了分析.
主要成果:
- 与PTCL-GATA3.3相比,PTCL-TBX21显示出明显较低的CD4阳性和高的内皮静脉计数.
- 在PTCL-TBX21中观察到免疫检查点相关基因 (PD-L1,LAG3,IDO1) 的更高表达.
- 在多变量分析中,PTCL-GATA3与明显更差的生存状况相关,是PFS的独立预后因素.
结论:
- 将PTCL-NOS分为PTCL-TBX21和PTCL-GATA3亚型的分类对预测日本患者的预后具有临床意义.
- 这种亚型分类可以为治疗策略提供信息,特别是关于使用瘤免疫检查点抑制剂.
- 需要进一步的研究来阐明这些亚型之间的差异性结果背后的确切机制.
更多相关视频
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.6K
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
10.9K
相关概念视频
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
